US › Healthcare

LifeMD Inc (LFMD)

US · Healthcare · Health Information Services

$2.37+3.49%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$47.3M

Revenue YoY

-24.0%

Net profit

$-7.1M

EPS

$-0.16

EPS estimate

$-0.20

Net margin

-15.0%

EPS came in at -0.16 against a street estimate of -0.20 — a beat of 20.0%.

Key statistics

Market cap

$110.5M

Forward P/E

12.9

P/B

13.27

Book value

$0.17

EPS (TTM)

$-0.51

52-week high

$5.44

52-week low

$2.06

50-day MA

$2.76

200-day MA

$3.64

Beta

2.16

Analyst view

Analysts rate LifeMD Inc a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $8.12.

Shareholding

Insiders

15.80%

Institutions

47.57%

Largest institutional holders

Fund	Stake
BlackRock Inc	6.29%
Federated Hermes Inc	5.69%
Vanguard Capital Management, LLC	3.59%
State Street Corp	2.73%
Renaissance Technologies Corp	2.24%
Geode Capital Management, LLC	2.21%
Prescott Group Capital Management LLC	1.86%
BRC Group Holdings Inc	1.32%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for LifeMD Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.